Skip to main content

Table 2 Recurrence and progression in patients with primary PUNLMP

From: Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth

 

Recur to PUNLMP No. (%)

Progress to low grade UC No. (%)

Progress to high grade UC No. (%)

Patients with recurrence/progression (N = 38)

17 (45)

18 (47)

3 (8)

Patients with one recurrence

10

12

1

Patients with multiple recurrences (Range)

7 (2 – 6)

6 (2 – 7)

2 (2 – 4)

Median/mean months to recurrence or progression (Range)

13/20 (5 – 78)

47/42 (5 – 87)

31/32 (4 – 61)